Innovations in Hepatitis C care and treatment to end the epidemic

  • Learning Series
Presenters:
Dr. Kate Salters
Research Scientist
BC Centre for Excellence in HIV/AIDS

Dr. Mark Hull
Research Scientist
BC Centre for Excellence in HIV/AIDS
Clinical Associate Professor
Division of Infectious Diseases
University of British Columbia
Share this video:
All Videos
Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025

Start typing and press enter to search